1. Introduction {#sec1}
===============

Infectious diseases caused by bacteria remain a serious public health problem in developing countries \[[@B1], [@B2]\]. The problem is exacerbated by the development of bacterial resistance to currently used antibacterial drugs \[[@B3], [@B4]\]. Among the major strategies to alleviate the current situation is to search for new antibacterial agents from natural sources as an alternative to synthetic antibiotics. Plants are known to produce a variety of secondary metabolites to protect themselves against a variety of their own pathogens, and therefore, those with documented traditional use appear to be a rich source of new antibacterial and antioxidant drugs. This prompts a revival in search of antibacterial and antioxidant agents from natural products.

*Gnidia* (of family Thymelaeaceae) is a widespread genus comprising about 152 species \[[@B5]\]. Although *Gnidia* species are being recognized for their ornamental value due to their bright and colorful flowers \[[@B6]\], they are also known for their use in traditional medicinal practice \[[@B7]--[@B9]\] and for their economic value as the flowers of the species are employed for dying leather \[[@B10]\]. *Gnidia involucrata* is one of the species growing in Ethiopia and locally called *shuntura* in Afan Oromo and *Yezngero telba* in Amharic. It is a perennial grass or subshrub that is being used in Ethiopia for the treatment of a wide array of diseases including malaria, rheumatism, and stomach parasite \[[@B11]\]. Its use as an insecticide and an insect repellant and also for the treatment of intestinal pain, mental problems, sexually transmitted diseases, and tuberculosis has been documented \[[@B12], [@B13]\]. In Ethiopia, the roots are used as a laxative and vermifuge \[[@B8]\]. In folk medicine, the roots are used to reduce the size of the vaginal orifice and as fish poison. Previous pharmacological reports indicate a variety of therapeutic uses such as antifungal agents \[[@B14]\], *α*-amylase inhibitors \[[@B15]\], and anti-inflammatory and gastroprotective agents \[[@B16]\].

Some species in the genus *Gnidia* were reported to contain secondary metabolites including manniflavanone, kaempferol-3-*O*-glucoside, *Gnidia* biflavonoid, vitexin, isovitexin, isoorientin, mangiferin, 2,3,4′,5,6-pentahydroxybenzophenone-4-*C*-glucoside, 2,4′,6-trihydroxy-4-methoxybenzophenone-2-*O*-glucoside, mhakoside A, and yuankanin \[[@B17], [@B18]\]. Despite the enormous traditional use of this species against various diseases, there is no information on the chemistry and antibacterial and antioxidant studies of the root barks of *G. involucrata*. Hence, in this study, we report for the first time the isolation of three compounds from the barks of *G. involucrata.* The antibacterial and antioxidant activities of the root bark extracts and isolated compounds are also reported herein for the first time.

2. Materials and Methods {#sec2}
========================

2.1. Plant Material {#sec2.1}
-------------------

The root barks of *G. involucrata* were collected in December 2016 from Kunde Gerasu Kebele, Meta Wolkite Woreda, West Shewa, Oromia, Ethiopia. Identification and authentication of the plant specimen was done at the National Herbarium of Addis Ababa University by Prof. Legesse Negash, and the voucher specimen (AB-002/2016) has been deposited.

2.2. Extraction and Isolation {#sec2.2}
-----------------------------

The air-dried root barks (300 g) of *G. involucrata* were milled into powder and then sequentially extracted with 1.5 L of *n*-hexane, EtOAc, and methanol each for 72 hours with occasional shaking at room temperature. The extracts were filtered and concentrated under reduced pressure using a rotary evaporator at 40°C to yield 2.4 g (0.8%), 12 g (4%), and 18 g (6%), respectively. The ethyl acetate extract (10 g) was adsorbed and fractionated over silica gel (200 g) column chromatography with increasing polarity of EtOAc in *n*-hexane to afford *ca*. 200 mL of each of 22 major fractions. The first four fractions were collected with 100% *n*-hexane. Fr5-6, Fr7, Fr8-9, Fr10-11, Fr12, Fr15-16, Fr17-18, and Fr19-20 were eluted with 9 : 1, 4 : 1, 7 : 3, 3 : 2, 1 : 1, 2 : 3, 1 : 4, and 1 : 9 *n*-hexane : EtOAc, respectively. The last fractions, Fr21-22, were collected with 100% EtOAc. Fractions 12 (875 mg) after silica gel column chromatography with 4 : 1 *n*-hexane : EtOAc as an eluent furnished compound **1** (46 mg). Fractions 17-18 (433 mg) showed three spots on TLC, which were combined and subjected to column chromatography on silica gel with 85 : 15 CH~2~Cl~2~ : MeOH as an eluent to give compound **2** (66 mg) and compound **3** (23 mg).

2.3. Antioxidant Activities {#sec2.3}
---------------------------

### 2.3.1. DPPH Radical-Scavenging Assay {#sec2.3.1}

The radical-scavenging activities of the extracts and isolated compounds were determined using the DPPH method \[[@B19], [@B20]\]. Four different concentrations of the methanol extract were mixed with 0.04% DPPH in MeOH to furnish 100, 50, 25, and 12 *μ*g/mL. The resulting solutions were placed in an oven at 37°C for 30 minutes and subjected to a UV-Vis spectrophotometer to record absorbance at 517 nm. Likewise, the radical-scavenging activities of the EtOAc extract and isolated compounds were evaluated following the same protocol. Ascorbic acid was used as a positive control. The percentage inhibition was calculated using the following formula:$$\begin{matrix}
{\%\text{ inhibition } = \frac{A_{\text{control}} - A_{\text{extract}}}{A_{\text{control}}} \times 100,} \\
\end{matrix}$$where *A* ~control~ is the absorbance of the DPPH solution and *A* ~extract~ is the absorbance of the test sample (DPPH solution plus sample).

### 2.3.2. Ferric Thiocyanate Method {#sec2.3.2}

The antilipid peroxidation potential of the extracts and isolated compounds was evaluated according to the method of Nagatsu \[[@B21]\]. 0.1 mg of each of the extracts and pure compounds of *G. involucrata*, 100 *μ*L of linoleic acid, EtOH (5 mL), and phosphate buffer (5 mL, 0.05 M, pH = 7) in water were separately added into a vial and incubated at 40°C in an oven. After 24 h, 0.1 mL from each was taken and added into a vial containing 75% of aqueous EtOH (7 mL), 30% of NH~4~SCN (0.15 mL), and 0.15 mL of 0.02 M FeCl~2~ in 3.5% HCl. Each was then subjected to UV-Vis spectrophotometry to record the absorbance at 500 nm. Absorbance of the blank and ascorbic acid was recorded in the same fashion. The percentage inhibition using the ferric thiocyante method is calculated according to the following formula:$$\begin{matrix}
{\text{Percentage inhibition} = 100 - \left( {\frac{A_{\text{s}}}{A_{\text{b}}} \times 100} \right)\%,} \\
\end{matrix}$$where *A* ~s~ is absorbance of the sample and *A* ~b~ is absorbance of the blank \[[@B22]\].

2.4. Antibacterial Activities {#sec2.4}
-----------------------------

The antibacterial activities of the ethyl acetate extract and isolated compounds from the barks of *G. involucrata* were tested against four bacterial strains using the disc diffusion method \[[@B23]\]. The American Type Culture Collection (ATCC) bacterial strains were obtained from Oromia Public Health Research, Capacity Building and Quality Assurance Laboratory Center, Adama, Ethiopia. The antibacterial activities of all samples were tested against three Gram-negative (*Escherichia coli* (ATCC 25922), *Proteus mirabilis* (ATCC 35659), and *Klebsiella pneumonia* (ATCC 700603)) and one Gram-positive (*Staphylococcus aureus* (ATCC 25923)) bacterial strains using the Mueller--Hinton agar (MHA) medium.

The test bacterial species were transferred from the stock cultures, and microbial suspensions were prepared in a nutrient broth for 24 h at 37°C until the turbidity of bacterial suspensions reached 1.5 × 10^8^ CFU·mL^−1^ by comparison with the 0.5 McFarland Standard. The disc diffusion assay was carried out by swabbing each test strain on the Mueller--Hinton (MH) agar plate using the 1/10 dilution of the microbial suspensions. Sterile paper discs (Whatman No.1 filter paper) impregnated with sterile 20 *μ*L (1.5 mg/mL) concentrations of the sample were placed onto the surface of the agar plate with equal distance from each other. A disc impregnated with sterile solvent (water) was taken as a negative control. Ciprofloxacin was used as the standard drug (positive control). After overnight incubation at 37°C, zones of inhibition around the disc were observed. Antimicrobial activity (*x*) was then characterized and classified based on the inhibition growth zone diameters and described as slight (*x* \< 4 mm diameter), medium (*x* = 4--8 mm), high (*x* = 8--12 mm), and very high (*x* \> 12 mm) \[[@B24]\].

3. Results and Discussion {#sec3}
=========================

3.1. Characterization of Isolated Compounds {#sec3.1}
-------------------------------------------

The root bark of *G. involucrata* was sequentially extracted with *n*-hexane, EtOAc, and MeOH. The EtOAc extract was subjected to column chromatography for further purification following its better radical-scavenging activity and peroxide formation inhibition and afforded three compounds **1**--**3** ([Figure 1](#fig1){ref-type="fig"}). The characterizations of the spectroscopic data for the identification of the structure of these compounds are detailed below.

Compound **1** was isolated as a white crystal from the EtOAc extract. Its TLC showed a spot at *R* ~f~ 0.42 with *n*-hexane : EtOAc (7 : 3) as a mobile phase which was visualized after dipping in vanillin/H~2~SO~4~. The ESI-MS provided a molecular ion peak at *m/z* 553 for \[M + Na\]^+^ and *m/z* 1083 for \[2 M + Na\]^+^, both corresponding to the molecular formula of C~34~H~58~O~4~, indicating six degrees of unsaturation. In the IR spectrum, the sharp absorption at 1684 cm^−1^ was attributed to the presence of the conjugated carbonyl group and the broad band at 3487 and 3328 cm^−1^ to the hydroxyl groups.

The ^1^H-NMR spectrum ([Table 1](#tab1){ref-type="table"}) indicated the presence of three protons in the aromatic region at *δ* ~H~ 6.88 (1H, d, *J* = 8.0 Hz), 7.04 (1H, dd, *J* = 1.8 and 8.0 Hz), and 7.13 (1H, pseudosinglet), which were assigned to H-5, H-6, and H-2, respectively, based on their coupling constants and mutual couplings. It also exhibited signals corresponding to a pair of doublets at *δ* ~H~ 6.25 and 7.57 with the vicinal coupling constant ^3^ *J* ~HH~ = 15.6 Hz. This indicated a *trans* geometry, and the signals were assigned to H-8 and H-7, respectively. These spectral features observed in the aromatic region in combination with the *trans* double-bond protons, which are *peri* to the carbonyl group (from the chemical shift value), were a clear indication of the presence of the caffeic acid moiety. The signal at *δ* ~H~ 4.19 (2H, t) was apparent for the existence of protons on oxygenated methylene carbon. The spectrum also showed signals accounting for 34 hydrogen atoms centered at *δ* ~H~ 1.27, indicating the presence of protons on many methylene groups. The signal at *δ* ~H~ 1.73 (4H) and *δ* ~H~ 0.90 (10H) revealed the presence of hydrogen atoms on two and five methylene groups, respectively. The presence of terminal methyl protons was evident at *δ* ~H~ 0.88.

The proton-decoupled ^13^C-NMR spectrum ([Table 1](#tab1){ref-type="table"}) of compound **1** with the aid of DEPT-135 showed signals corresponding to 34 carbon atoms including five methine groups (two olefinic and three aromatic), twenty-four methylene groups (one oxygenated), four quaternary carbon atoms (one carbonyl carbon), and a methyl carbon atom. The highly downfield-shifted carbon signal at *δ* ~C~ 168.0 and the two olefinic carbon atoms at *δ* ~C~ 143.9 and 115.5 were evident for the presence of the *α*,*β*-unsaturated carbonyl group of the caffeic acid moiety. The signal at *δ* ~C~ 64.9 for the oxygenated methylene carbon and long aliphatic chain revealed the presence of caffeic acid ester. Based on these spectroscopic data and the literature information, the structure of compound **1** was concluded to be pentacontanyl caffeate, previously reported from the leaves of *Artemisia argyi* except for the long chain alcohol component \[[@B25]\].

The spectral data of compound **1** are in agreement with the structure shown in [Figure 1](#fig1){ref-type="fig"}.

Compound **2** was obtained as a yellow crystal with an *R* ~f~ value of 0.56 (in 15% methanol in dichloromethane as a mobile phase), which was visualized after dipping in iodine solution. Its molecular formula C~34~H~48~O~8~ was deduced from ESI-MS, showing a peak at *m*/*z* 1191 for \[2 M + Na\]^+^, indicating eleven indices of hydrogen deficiency. The IR spectrum showed a stretching band due to the presence of hydroxyl at 3415 cm^−1^. The strong absorption bands at 2925 cm^−1^ and 1714 cm^−1^ were evident for the presence of the C-H stretching of alkyl groups and *α*,*β*-conjugated carbonyl, respectively, whereas the bands at 1641 and 1259 cm^−1^ were apparent for C=C and C-O stretching, respectively.

The ^1^H-NMR spectrum ([Table 2](#tab2){ref-type="table"}) showed signals for four olefinic protons at *δ* ~H~ 5.76 (1H, d, *J* = 15.2 Hz, H-2′), 6.16 (1H, m, H-5′), 5.69 (1H, br.s, H-4′), and 7.21 (1H, dd, *J* = 10 Hz, H-3′). The downfield-shifted olefinic proton signal at *δ* ~H~ 7.58 was assigned to proton at C-1, *beta* to the carbonyl group. Signals in the ^1^H-NMR spectrum at *δ* ~H~ 4.02 and 3.95 were due to the presence of oxygenated methylene protons. The signals at *δ* ~H~ 2.47 and 2.59 also accounted for the presence of methylene protons in different environments. The spectrum showed the presence of six methyl protons at *δ* ~H~ 2.10 (3H, s H-2″), 1.74 (3H, s, H-19), 1.25 (3H, s, H-16), 1.2 (3H, s, H-17), and 0.88 (6H, t, H-12′ and H-18). The spectrum also showed signals accounting for 8 hydrogen atoms centered at *δ* ~H~ 1.27, indicating the presence of protons on many overlapping methylene groups.

The proton-decoupled ^13^C-NMR spectrum with the aid of DEPT-135 showed the presence of eleven methine groups, eight methylene groups, 6 six methyl groups, and nine quaternary carbons. The downfield-shifted signal observed at *δ* ~C~ 209.3 was evident for the presence of the *α*,*β*-unsaturated carbonyl group. In fact, the high chemical shift value for this conjugated carbonyl (*δ* ~C~ 209.3) could be due to the deshielding and steric effects of the *di-alpha* substituent, which could not allow the planarity of the carbonyl group with the double bond. The signals at *δ* 173.9 and 167.2 were apparent for the presence of two ester moieties. The signals observed at *δ* ~C~ 118.8, 145.3, 128.3, and 145.7 were evident for the olefinic groups. The other signals due to quaternary carbons were observed at *δ* ~C~ 132.8, 73.7, 140.7, 78.4, 65.7, and 25.7. The ^13^C-NMR spectral data of compound **2** were very similar to those reported for prostratin Q, which was isolated from *Wikstroemia chamaedaphne* \[[@B26]\], except for additional methylene groups to the long chain aliphatic ester ([Table 2](#tab2){ref-type="table"}), and aquimavitalin extracted from *Aquilaria malaccensis*, except for the length of the fatty acid moiety and number of olefinic protons \[[@B27]\]. Therefore, based on this spectroscopic evidence, compound **2** was identified as prostratin (12-*O*-phorbol-13-acetate).

Prostratin (12-*O*-phorbol-13-acetate), a nontumor-promoting phorbol ester, reported to inhibit HIV-1 cell entry and replication, blocks completion of reverse transcription of the HIV-1 genome in lymphoid tissue and infection of CD4^+^ T lymphocytes and at the same time reactivates virus from latency, restricts primary resting of CD4^+^ T-cell susceptibility to HIV-1 infection in primary blood mononuclear cells (PBMCs) and in lymphoid tissue \[[@B28], [@B29]\], has antireplicative and anticytopathic activities against HIV \[[@B30]\], and inhibits ornithine decarboxylase induction, *edema*, and hyperplasia \[[@B31]\]. 12-*O*-Dodeca-2,4-dienoylphorbol-13-acetate isolated in this work from this plant may exhibit activities displayed by those compounds containing the prostratin nucleus. Therefore, the presence of this compound adds one positive attribute to the root barks of this plant.

Compound **3** was obtained as pale yellow needles. Its TLC profile showed a spot at *R* ~f~ value 0.60 in 15% CH~2~Cl~2~ in MeOH as a mobile phase which was visualized after dipping in iodine. The IR spectrum of compound **3** showed the presence of hydroxyl and carbonyl stretching at 3328 and 1641 cm^−1^, respectively. The ^13^C-NMR spectral data with the aid of DEPT-135 indicated a total of fifteen carbon atoms including seven methine groups, one methylene group, and seven quaternary carbon atoms. The downfield signal observed at *δ* ~C~ 197.2 was evident for the presence of the carbonyl group. The signal at *δ* ~C~ 47.9 was indicative of the presence of aliphatic carbon in the ring. Other signals were observed at *δ* ~C~ 83.4, 164.5, 96.1, 166.1, 94.8, 163.3, 101.9, 128.5, 129, 114.9, and 157.6. Of these, the signals situated at *δ* ~C~ 197.2, 164.5, 166.1, 163.3, 101.9, 128.5, and 157.6 accounted for quaternary carbons. These spectral data are consistent with the spectral data reported for naringenin, previously reported from *Nyctanthes arbortristis* \[[@B32]\].

3.2. Antioxidant Activities {#sec3.2}
---------------------------

### 3.2.1. DPPH Radical-Scavenging Assay {#sec3.2.1}

The extracts and isolated compounds were assessed for their radical-scavenging activities using DPPH. The results showed that the ethyl acetate and methanol extracts and compound **1** and compound **2** inhibited the DPPH radical by 70.7, 66.9, 85.8, and 52.8% at 100 *μ*g/mL, respectively ([Table 3](#tab3){ref-type="table"}). The IC~50~ parameter is also applied to express the antioxidant activity of compounds or mixtures by the DPPH \[[@B33]\]. In view of this, the radical-scavenging activity of the samples analyzed in this work was also expressed in terms of IC~50~ value. The results showed that the EtOAc extract, the methanol extract, and compounds **1** and **2** displayed IC~50~ values of 7.9, 17.7, 73.0, and 84.9, respectively. The best activity was shown by compound **1** which likely accounts for the activity displayed by the EtOAc extract. The radical-scavenging activity of compound **1** was found comparable with that of ascorbic acid which inhibits the radical by 90%. The activity displayed by compound **1** is likely due to the presence of phenolic hydroxyl groups. Therefore, ethyl acetate extract and compound **1** may be used for the treatment of various life-threatening diseases caused by free radicals.

### 3.2.2. Ferric Thiocyanate Methods {#sec3.2.2}

The degree of lipid peroxidation which was evaluated using the ferric thiocyanate method can be used to measure the antioxidant potential of compounds or extracts. [Table 3](#tab3){ref-type="table"} shows the results of the antilipid peroxide formation of the root bark extracts and constituents of *G. involucrata*.

As depicted in [Table 3](#tab3){ref-type="table"}, the EtOAc extract and compound **1** inhibit peroxide formation by 84 and 86%, respectively, demonstrating their potential in preventing the formation of lipid peroxides. The results turned out to be comparable with those of ascorbic acid which inhibited the DPPH radical by 87%. On the contrary, the MeOH extract and compound **2** were shown to have low ability of inhibiting peroxide formation compared with the natural antioxidant. This indicates that the antioxidant compound of the root bark extracts of *G. involucrata* resides in the EtOAc extract, with the main active ingredient found to be compound **1**.

3.3. Antibacterial Activities {#sec3.3}
-----------------------------

The antibacterial activity of the EtOAc extract and isolated compounds **1**--**3** of the root barks of *G. involucrata* was investigated using the agar well diffusion method, against some selected human pathogens, with the results being presented in [Table 4](#tab4){ref-type="table"}.

The extract displayed a broad range of antibacterial activities against all tested pathogens used in this study including *S*. *aureus*, *E*. *coli*, *P*. *mirabilis*, and *Klebsiella pneumonia* with inhibition zones of 23, 14, 12, and 12 mm, respectively. The activity was pronounceable against *S*. *aureus* compared to ciprofloxacin used as the standard antibiotic. The wide zone of inhibition of the EtOAc extract showed that it had great potential as a remedy for infectious diseases caused by bacterial pathogens. Among the isolated compounds, compound **2** was found active against *S*. *aureus* and *E*. *coli* with inhibition zones of about 8 and 11 mm, respectively. On the contrary, compound **3** displayed modest activities against *P*. *mirabilis*, *E*. *coli*, and *K*. *pneumonia* with inhibition zones of 7, 12, and 8 mm, respectively. The better activity of the crude extract could be due to the synergistic interactions of several phytochemicals present in the extract, which cannot be the case when pure compounds are evaluated alone.

4. Conclusion {#sec4}
=============

The ethyl acetate extract after silica gel column chromatography furnished three compounds identified as pentacontanyl caffeate (**1**), 12-*O*-dodeca-2,4-dienoylphorbol-13-acetate (**2**), and naringenin (**3**). This is the first report of caffeic acid ester derivative (**1**) and its kind from the genus *Gnidia*. The work presented herein has also demonstrated that the EtOAc extract of the root bark of *G. involucrata* had strong antibacterial activity compared to ciprofloxacin used as a positive control. The antioxidant activities displayed by the EtOAc extract and compound **1** were significant compared with those displayed by ascorbic acid, indicating the potential of the root barks of this species as natural antioxidants. Therefore, the biological activities displayed by the EtOAc extract and isolated compounds from the root bark of *G. involucrata* corroborate the traditional use of this plant against various ailments caused by bacteria. Further comprehensive evaluations including *in vivo* antibacterial activity tests are recommended for conclusive decision on potential candidacy of the plant for formulation and medicinal uses.

The authors are grateful to Adama Science and Technology University for the fund.

Data Availability
=================

The NMR spectra used for the interpretation of compounds in this study are included as supplementary information files. Other data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest
=====================

The authors declare that they have no conflicts of interest.

Supplementary Materials {#supplementary-material-1}
=======================

###### 

Supporting File 1: 1H-NMR spectrum of compound 1. Supporting File 2: 13C-NMR spectrum of compound 1. Supporting File 3: DEPT-135 spectrum of compound 1. Supporting File 4: 1H-NMR spectrum of compound 2. Supporting File 5: 13C-NMR spectrum of compound 2. Supporting File 6: DEPT-135 spectrum of compound 2.

###### 

Click here for additional data file.

![Structures of isolated compounds **1** (a), **2** (b), and **3** (c).](JTM2019-8486214.001){#fig1}

###### 

^1^H- and ^13^C-NMR (CDCl~3~) spectral data of compound **1** and data of closely related compounds in the literature \[[@B20]\].

  No.       ^1^H-NMR data of compound **1**       ^1^H-NMR spectral data reported in the literature \[[@B25]\]   ^13^C-NMR data of compound **1**   ^13^C-NMR spectral data reported in the literature \[[@B25]\]
  --------- ------------------------------------- -------------------------------------------------------------- ---------------------------------- ---------------------------------------------------------------
  1         ---                                                                                                  127.4                              127.6
  2         7.13 (1H, br.s)                       7.16 (1H, d, *J* = 1.8)                                        114.4                              115.2
  3         ---                                   ---                                                            145.0                              146.2
  4         ---                                   ---                                                            146.5                              148.6
  5         6.88 (1H, d, *J* = 8.0 Hz)            6.87 (1H, d, *J* = 8.0)                                        115.4                              116.3
  6         7.04 (1H, dd, *J* = 1.8 and 8.0 Hz)   7.04 (1H, dd, *J* = 8.0 and 1.8)                               122.3                              122.4
  7         7.57 (1H, d, *J* = 15.6)              7.53 (1H, d, *J* = 15.9)                                       143.9                              145.5
  8         6.25 (1H, d, *J* = 15.6)              6.28 (1H, d, *J* = 15.9)                                       115.5                              115.8
  9         ---                                                                                                  168.0                              167.4
  1′        4.19 (2H, t)                          4.14 (2H, t, *J* = 6.7)                                        64.9                               64.6
  2′        1.73 (2H, m)                          1.68 (m)                                                       31.9                               32.6
  3′        1.73 (2H, m)                                                                                         29.7                               NR
  4′--24′   1.27--0.88 (42H)                                                                                     29.7--22.6                         NR
  25′       0.88 (3H, t)                                                                                         14.1                               14.3

NR: not reported.

###### 

^1^H- and ^13^C-NMR (CDCl~3~) spectral data of compound **2** and literature reported for closely related compounds \[[@B26]\].

  No.       ^1^H-NMR spectral data of compound **2**   ^1^H-NMR literature data \[[@B26]\]   ^13^C-NMR spectral data of compound **2**   ^13^C-NMR literature data \[[@B26]\]
  --------- ------------------------------------------ ------------------------------------- ------------------------------------------- --------------------------------------
  1         7.58 (1H, s)                               7.57 (1H, s)                          160.8                                       161
  2         ---                                        ---                                   132.8                                       133
  3         ---                                        ---                                   209.3                                       209.1
  4         ---                                        ---                                   73.7                                        74
  5(a)      2.47 (1H, d)                               2.46 (1H, d)                          38.4                                        38.9
  5(b)      2.59 (1H, d)                               2.53 (1H, d)                                                                       
  6         ---                                                                              140.7                                       140.7
  7         5.69 (1H, br.s)                            5.66 (1H, d)                          129.2                                       129.5
  8         3.29 (1H, m)                               3.22 (1H, dd)                         38.9                                        39.3
  9         ---                                                                              78.4                                        78.4
  10        3.24 (1H, br.s)                            3.23 (1H, s)                          56.0                                        56.4
  11        2.16 (1H, m)                               2.15 (1H, m)                          43.0                                        43.4
  12        5.43 (1H, d)                               5.44 (1H, d)                          76.6                                        76.8
  13        ---                                                                              65.7                                        66
  14        1.09 (1H, d)                               1.08 (1H, d)                          36.3                                        36.6
  15        ---                                                                              25.7                                        26
  16        1.25 (3H, s)                               1.24 (3H, s)                          23.8                                        24
  17        1.2 (3H, s)                                1.19 (3H, s)                          16.8                                        17
  18        0.88 (3H, d)                               0.87 (3H, d)                          14.4                                        14.6
  19        1.74 (3H, s)                               1.75 (3H, d)                          10.1                                        10.3
  20(a)     3.95 (1H, d)                               3.97 (1H, d)                          68.0                                        68.3
  20(b)     4.02 (1H, d)                               4.02 (1H, d)                                                                       
  1′        ---                                                                              167.2                                       167.3
  2′        5.76 (1H, d)                               5.76 (1H, d)                          118.8                                       119.1
  3′        7.21 (1H, dd)                              7.21 (1H, dd)                         145.7                                       145.8
  4′        5.69 (1H, br.s)                            6.16 (1H, dd)                         128.3                                       128.5
  5′        6.16 (1H, m)                               6.13 (1H, m)                          145.3                                       145.5
  6′        2.14 (2H, m)                               2.13 (2H, m)                          33.0                                        33.3
  7′        1.40 (2H, m)                               1.41 (2H, m)                          32.9                                        28.6
  8′--11′   1.27 (8H, m)                               1.28 (4H, m)                          31.8--22.6                                  31.6
  12′       0.88 (3H, t)                               0.86 (3H, t)                          14.1                                        14.2
  1″                                                                                         173.9                                       174
  2″        2.10 (3H, s)                               2.08 (3H, s)                          21.1                                        21.3

###### 

DPPH radical-scavenging and antilipid peroxidation activities of extracts (EtOAc and MeOH) and isolated compounds (**1** and **2**).

  Samples          \% DPPH inhibition   Antilipid peroxidation inhibition (%)                               
  ---------------- -------------------- --------------------------------------- ------------- ------------- -----------
  EtOAc extract    70.7 ± 0.02          64.1 ± 0.04                             57.5 ± 0.03   46.2 ± 0.05   84 ± 0.04
  MeOH extract     66.9 ± 0.01          61.3 ± 0.02                             54.7 ± 0.01   41.5 ± 0.10   45 ± 0.06
  Compound **1**   85.8 ± 0.03          79.2 ± 0.05                             73.4 ± 0.01   65.0 ± 0.02   86 ± 0.01
  Compound **2**   52.8 ± 0.01          41.5 ± 0.01                             34.9 ± 0.02   16.9 ± 0.03   33 ± 0.09
  Ascorbic acid    90 ± 0.02                                                                                87 ± 0.02

Data are reported as mean ± SEM; ascorbic acid was used as a positive control.

###### 

Zone of bacterial growth inhibition (mm) of the EtOAc extract and isolated compounds from the root barks of *G. involucrata* at 1.5 mg/mL.

  Samples          Zone of bacterial growth inhibition in mm                           
  ---------------- ------------------------------------------- ----------- ----------- -----------
  EtOAc extract    23 ± 0.02                                   12 ± 0.01   14 ± 0.04   12 ± 0.03
  Compound **1**   6 ± 0.01                                    6 ± 0.01    6 ± 0.02    6 ± 0.04
  Compound **2**   8 ± 0.02                                    6 ± 0.02    11 ± 0.02   6 ± 0.02
  Compound **3**   6 ± 0.01                                    7 ± 0.02    12 ± 0.03   8 ± 0.01
  Ciprofloxacin    22 ± 0.03                                   24 ± 0.03   21 ± 0.02   19 ± 0.02

[^1]: Academic Editor: Aditya Prasad Dash
